Nutex Health (NUTX) to Release Quarterly Earnings on Tuesday

Nutex Health (NASDAQ:NUTX - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect Nutex Health to post earnings of ($0.15) per share and revenue of $81.09 million for the quarter.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $81.30 million during the quarter, compared to analyst estimates of $81.13 million.

Nutex Health Trading Down 4.1 %

NASDAQ NUTX traded down $4.87 during trading hours on Tuesday, hitting $114.19. 6,376 shares of the company were exchanged, compared to its average volume of 57,674. The stock has a market cap of $631.21 million, a PE ratio of -12.23 and a beta of 0.27. The stock has a 50-day moving average price of $79.65 and a 200 day moving average price of $51.17. Nutex Health has a 52 week low of $4.16 and a 52 week high of $152.51. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.

Insider Buying and Selling

In other news, CFO Jon Christian Bates purchased 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The stock was acquired at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the acquisition, the chief financial officer now directly owns 4,888 shares in the company, valued at $399,887.28. This represents a 25.72 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 38.52% of the stock is owned by company insiders.

Institutional Trading of Nutex Health

An institutional investor recently raised its position in Nutex Health stock. Bank of America Corp DE boosted its stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 6,590.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,074 shares of the company's stock after purchasing an additional 2,043 shares during the quarter. Bank of America Corp DE's holdings in Nutex Health were worth $66,000 at the end of the most recent quarter. Institutional investors own 5.32% of the company's stock.

Wall Street Analyst Weigh In

Separately, Maxim Group increased their target price on shares of Nutex Health from $75.00 to $100.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.